✦ LIBER ✦

Phase II Study of Cladribine (2-Chlorodeoxyadenosine) in Relapsed or Refractory Adult T-Cell Leukemia-Lymphoma

✍ Scribed by Kensei Tobinai; Naokuni Uike; Yoshio Saburi; Takaaki Chou; Tetsuya Etoh; Masato Masuda; Fumio Kawano; Masao Matsuoka; Hirokuni Taguchi; Torahiko Makino; Yoshinobu Asano; Kazuo Tamura; Yasuo Ohashi

Publisher: Carden Jennings Publishing
Year: 2003
Tongue: English
Weight: 82 KB
Volume: 77
Category: Article
ISSN: 0925-5710
DOI: 10.1007/bf02986621

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A multicenter phase II study of darinapa

A multicenter phase II study of darinaparsin in relapsed or refractory Hodgkin's and non-Hodgkin's lymphoma

✍ Peter J. Hosein; Michael D. Craig; Martin S. Tallman; Ralph V. Boccia; Brian L. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 850 KB

ABVD: doxorubicin,

Phase 2 trial of rituximab and bortezomi

Phase 2 trial of rituximab and bortezomib in patients with relapsed or refractory mantle cell and follicular lymphoma

✍ Robert A. Baiocchi; Lapo Alinari; Mark E. Lustberg; Thomas S. Lin; Pierluigi Por 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 257 KB 👁 1 views

Phase II study of sphingosomal vincristi

Phase II study of sphingosomal vincristine in patients with recurrent or refractory adult acute lymphocytic leukemia

✍ Deborah A. Thomas; Andreas H. Sarris; Jorge Cortes; Stefan Faderl; Susan O'Brien 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB 👁 2 views

A multicenter, open, noncomparative, pha

A multicenter, open, noncomparative, phase II study of the combination of cladribine (2-chlorodeoxyadenosine), cytarabine, granulocyte colony-stimulating factor and mitoxantrone as induction therapy in refractory acute myeloid leukemia: a report of the Polish Adult Leukemia Group

✍ A. Wrzesień-Kuś; T. Robak; A. Wierzbowska; E. Lech-Marańda; A. Pluta; E. Wawrzyn 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 150 KB

Phase 1 multicenter study of vincristine

Phase 1 multicenter study of vincristine sulfate liposomes injection and dexamethasone in adults with relapsed or refractory acute lymphoblastic leukemia

✍ Deborah A. Thomas; Hagop M. Kantarjian; Wendy Stock; Leonard T. Heffner; Stefan 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 142 KB 👁 1 views

Phase II trial of etoposide and cisplati

Phase II trial of etoposide and cisplatin in patients with refractory and relapsed non-Hodgkin's lymphoma: Cancer and leukemia group B study 8351

✍ Rybak, Mary Ellen ;Anderson, James ;Kaplan, Richard ;Budman, Daniel R. ;Vincigue 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 435 KB

## Abstract A phase‐II study was conducted by the Cancer and Leukemia Group B (CALGB) in patients with refractory and relapsed non‐Hodgkin's lymphoma (NHL) to assess the activity of the combination of etoposide and cisplatin. Sixty‐five patients were entered on study, and 51 patients were evaluated